Mutual of America Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-86,224
Closed -$4.53M 1693
2020
Q3
$4.53M Buy
86,224
+80,485
+1,402% +$3.33M 0.06% 416
2020
Q2
$191K Buy
5,739
+721
+14% +$23K ﹤0.01% 1142
2020
Q1
$136K Buy
5,018
+963
+24% +$26.8K ﹤0.01% 1156
2019
Q4
$80K Buy
4,055
+415
+11% +$6.64K ﹤0.01% 1242
2019
Q3
$47K Buy
3,640
+118
+3% +$1.43K ﹤0.01% 1351
2019
Q2
$44K Buy
3,522
+706
+25% +$9.37K ﹤0.01% 1373
2019
Q1
$41K Buy
2,816
+446
+19% +$5.7K ﹤0.01% 1343
2018
Q4
$26K Buy
2,370
+880
+59% +$12.2K ﹤0.01% 1406
2018
Q3
$39K Buy
1,490
+1,205
+423% +$32.6K ﹤0.01% 1303
2018
Q2
$6K Buy
+285
New +$6.12K ﹤0.01% 1363
2014
Q2
Sell
-74,800
Closed -$871K 1292
2014
Q1
$871K Buy
+74,800
New +$1.27M 0.02% 1022

Mutual of America Capital Management's MNTA Position: Q4 2020 in Review

Mutual of America Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 86,224 shares — an estimated $4.53M sold.

Mutual of America Capital Management first reported a position in MNTA in Q1 2014 and held it in 11 quarters. The position peaked at $4.53M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Mutual of America Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Mutual of America Capital Management sold 86,224 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $4.53M.
  • Mutual of America Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2014 and held it in 11 quarters.
  • Mutual of America Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $4.53M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Mutual of America Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.